BioXcel Therapeutics
BTAI
BTAI
104 hedge funds and large institutions have $431M invested in BioXcel Therapeutics in 2020 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 35 increasing their positions, 20 reducing their positions, and 10 closing their positions.
Holders
104
Holders Change
+33
Holders Change %
+46.48%
% of All Funds
2.14%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.06%
New
43
Increased
35
Reduced
20
Closed
10
Calls
$27.9M
Puts
$13.3M
Net Calls
+$14.6M
Net Calls Change
+$14.9M
Top Buyers
1 |
1
State Street
Boston,
Massachusetts
|
$51.7M |
2 |
2
AllianceBernstein
Nashville,
Tennessee
|
$26.7M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$16.6M |
4 |
LGM
4
Logos Global Management
San Francisco,
California
|
$15.9M |
5 |
5
BlackRock
New York
|
$38.2M |